BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33871952)

  • 41. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
    Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
    Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
    Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
    Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor.
    Watanabe T; Honma Y; Yonemori K; Sunami K; Yoshimoto S; Mori T
    Head Neck; 2024 Mar; 46(3):E26-E31. PubMed ID: 38018800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
    Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
    Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A; Hyrcza MD; Leivo I
    Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG; Desrichard A; Katabi N; Makarov V; Walsh LA; Lee KW; Wang Q; Armenia J; West L; Dogan S; Wang L; Ramaswami D; Ho AL; Ganly I; Solit DB; Berger MF; Schultz ND; Reis-Filho JS; Chan TA; Morris LG
    Clin Cancer Res; 2016 Sep; 22(18):4623-33. PubMed ID: 27103403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological and immunohistochemical behavior of ductal carcinoma of the salivary and lacrimal gland in a Mexican Mestizo population.
    Luna-Ortiz K; Dominguez-Malagon H; Corredor-Alonso GE; Reynoso-Noveron N; Herrera-Ponzanelli C; Luna-Peteuil Z; Zacarias-Ramon LC
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):327-333. PubMed ID: 33763743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
    Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
    Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
    Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
    Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
    Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
    Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene.
    Balatti V; Oghumu S; Bottoni A; Maharry K; Cascione L; Fadda P; Parwani A; Croce C; Iwenofu OH
    Head Neck Pathol; 2019 Sep; 13(3):344-354. PubMed ID: 30259272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma.
    Liang L; Williams MD; Bell D
    Head Neck Pathol; 2019 Dec; 13(4):529-534. PubMed ID: 30390196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
    Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
    Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
    Wang K; Russell JS; McDermott JD; Elvin JA; Khaira D; Johnson A; Jennings TA; Ali SM; Murray M; Marshall C; Oldham DS; Washburn D; Wong SJ; Chmielecki J; Yelensky R; Lipson D; Miller VA; Stephens PJ; Serracino HS; Ross JS; Bowles DW
    Clin Cancer Res; 2016 Dec; 22(24):6061-6068. PubMed ID: 27334835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys Mutation.
    Agaimy A; Mueller SK; Bumm K; Iro H; Moskalev EA; Hartmann A; Stoehr R; Haller F
    Am J Surg Pathol; 2018 Aug; 42(8):1076-1082. PubMed ID: 29738361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secretory Carcinoma of the Skin Harboring ETV6 Gene Fusions: A Cutaneous Analogue to Secretory Carcinomas of the Breast and Salivary Glands.
    Bishop JA; Taube JM; Su A; Binder SW; Kazakov DV; Michal M; Westra WH
    Am J Surg Pathol; 2017 Jan; 41(1):62-66. PubMed ID: 27631515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.
    Salgado CM; Alaggio R; Reyes-Múgica M; Zin A; de Vito R
    Head Neck Pathol; 2021 Sep; 15(3):796-802. PubMed ID: 33459993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.